Clinical & research – PositiveBlockchain.io

Encrypgen

Paul — Sat, 06 Jul 2019 22:00:00 +0000

THE DNA DATA MARKETPLACE
If you’ve done a DNA test you can sell your de-identified data to researchers, helping science and potentially earning back the cost of the test itself. Your data is valuable!

Zenome

Lucas — Fri, 26 Apr 2019 22:00:00 +0000

From the point of view of abuse, a predisposition to dependencies on various substances, drug intolerance and a predisposition to dangerous diseases are also interesting to note. Finally, the genome records all the information about your donor compatibility with different people. If someone has the opportunity to find out that your organs will suit him perfectly that will make you a potential target.
So now we can go to the Zenome solution. We are going to create blockchain-based genomics ecosystem. Why blockchain?
This technology is good if used correctly.
It will allow:
– secure storage of genetic data
– exchange
– getting profit from individuals
– new genomic based services
– transparency of the requests
– rating system
– payment system
All that will allow you to create ecosystem of genomic information exchange.

The Zenome solution is unique, because it allows different types of data to be stored using appropriate technologies. So genomic data is stored securely divided by small parts on the distributed network. Transaction data and rating system lives on the ethereum blockchain. All calculations can be done on nodes, managed by private blockchain. The scheme is flexible enough for all those activities . For example now there are blockchain based solutions for data storage and calculations so the Zenome team doesn’s exclude future partnership with other startups in that field.

Geneyx

Lucas — Fri, 26 Apr 2019 22:00:00 +0000

GRP by Geneyx enables millions of individuals, physicians, geneticists, bioinformaticians, genetic labs, sequencing service providers and researchers in either private pharma or academic institutes to harness the full potential of the abundance of genomic data that is currently generated at increasing pace and constantly increased quality and coverage.

The GRP allows the individual genomic data to become a personal asset, therefore maximizes its value, both to the genome owner on the one hand and to data consumer on the other. It enables accumulation of genetic data while maintaining the highest standards of privacy, security and immutability. Its innovative features enables your single data point to become part of the big data, which transforms it into useful information.

The team is creating a decentralized GRP, utilizing cutting edge blockchain methodology to keep an unconditional strict privacy regulation.

Aspcets:

Periodical basic genome re-analysis, followed by a summarised report for the patient to further consult with his primary physician.

Strict masking the genome identifier codes (patentable method).

Anonymous compensation of the genome owners for contributing their data via smart contracts.

Nebula Genomics

Lucas — Fri, 26 Apr 2019 22:00:00 +0000

Reading Time: < 1 minutes Nabula Genomics adresses data security issues and ensure that data gets from the source to its end-user without any middlemen: end-user will be able to exchange its sequence with pharmaceutical companies in exchange for tokens, instead of having a middlman (usually the company who sequences the genome) selling it.

Arna Genomics

Lucas — Fri, 26 Apr 2019 22:00:00 +0000

Reading Time: < 1 minutes ARNA Genomics introduces a revolutionary solution for cancer diagnostics and treatment biotechnologies — blockchain-ecosystem ARNA Panacea. – ARNA Panacea by design is platform which allows not only processing of clinical trials data but also support for researchers during R&D phase and marketplace for all types of market participants involved in clinical trials as well as […]

Embleema

Paul — Sat, 05 Jan 2019 09:53:13 +0000

Embleema’s blockchain network offers a novel way to put patients at the center of clinical research by letting them own their health data, disrupting the slow, costly, manual and opaque process by which low quality health data is currently collected by pharmaceutical companies through Contrat Research Organisation, to monitor the efficacy of new investigational drugs. Connecting patients directly to medical research and incentivizing them to share their data with tokens, blockchain is the decentralized technology everyone was waiting for to move away from the current linear process of drug approvals, to a new iterative model where trustworthy digital health data is shared in real time between patients, life sciences and regulators. The 21st Century Cures Act (2016) gave the FDA a mandate to accelerate approvals if more patient real world data was shared proactively by pharma. Embleema’s blockchain speeds up this process with patient buy-in, accelerating time to market new drugs.

We believe Blockchain technology is the ideal standard that can provide patients, healthcare professionals, health insurance payers and providers a shared, comprehensive, longitudinal, and trusted view of a patient’s medical history. When preserved as a ledger of transactions, a patient’s medical history is clearly accessible to all stakeholders with due authorization from the patient, and the best treatment option can be determined.

PatientTruth is a Cloud and Blockchain-based software solution that connects to a patient’s different medical records at the various centers of healthcare services, such as hospitals, primary care practices, rehabilitative centers, nursing homes and urgent care centers, and chains them into a consistent, comprehensive, and tamper-proof medical history. PatientTruth provides a holistic view of a patient’s medical history across providers and care centers.